Investors

Presentations

Title Date Documents

RXi Presentation at 19TH Annual BIO CEO & Investor Conference

RXi Presentation at 9th Annual Biotech Showcase Conference

RXi Q3 2016 Earnings Conference Call Transcript

RXi Presents at BIO Investor Forum 2016

RXi Presents at 16th Annual Biotech in Europe Forum Global Partnering & Investment Event

Self-Delivering RNAi Compounds (sd-rxRNA®) for the Treatment of Ocular Disorders - Presented at: 4th Annual Targeting Ocular Disorders Conference

BioPharm America™ International Partnering Conference

RXi Q2 2016 Earnings Conference Call Transcript

Non-clinical Development of RXI-109 to Support Clinical Investigation in Dermal Indications – Presented at: 18th Annual TIDES: Oligonucleotide and Peptides Therapeutics Conference

Development of RXI-109 for Dermal and Ocular Indications – Presented at: 18th Annual TIDES: Oligonucleotide and Peptides Therapeutics Conference